MedPath

Meditative Neurofeedback for Depression

Not Applicable
Recruiting
Conditions
Depression - Major Depressive Disorder
Depression Disorders
Registration Number
NCT06675240
Lead Sponsor
University of California, San Diego
Brief Summary

The goal of this open-label single-arm study is to test a meditative neurofeedback intervention for depressed mood.

Detailed Description

The goal of this open-label single-arm study is to test whether a 10-session meditative neurofeedback intervention significantly alleviates depressive symptons as well as improves secondary outcomes of rumination and mindfulness.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
27
Inclusion Criteria
  • moderate depression per PHQ9 symptom ratings
Exclusion Criteria
  • active substance abuse/dependence
  • psychotic disorders
  • bipolar disorder
  • displaying acutely suicidal behaviors

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
PHQ98 weeks

Depression Symptoms on the Patient Health Questionnaire 9-item (PHQ9) scale, min 0 max 27 with lower scores representing better outcome

Secondary Outcome Measures
NameTimeMethod
MAAS8 weeks

Mindfulness on the Mindful Attention Awareness Scale (MAAS), min 6 max 84 with higher scores representing better outcome

GAD78 weeks

Anxiety symptoms on the Generalized Anxiety Disorder 7-item (GAD7) scale, min 0 max 21 with lower scores representing better outcome

RRQ8 weeks

Rumination on the Ruminative Response Questionnaire (RRQ) scale, min 22 max 88 with lower scores representing better outcome

Trial Locations

Locations (1)

University of California San Diego

🇺🇸

La Jolla, California, United States

University of California San Diego
🇺🇸La Jolla, California, United States
Jyoti Mishra
Contact
858-232-2855
jymishra@ucsd.edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.